WHO releases guidelines endorsing GLP-1 drugs for obesity treatment

The World Health Organization has issued its first guideline on using GLP-1 medicines to treat obesity, emphasizing that these therapies can support long-term management of obesity alongside lifestyle changes, but should be part of a comprehensive approach. The guideline highlights the importance of equitable access, health system readiness, and multisectoral strategies to address the global obesity crisis, which affects over 1 billion people and causes millions of deaths annually.